Association between single nucleotide polymorphisms and side effects in nivolumab treated NSCLC patients

被引：0
|
作者：
Bins, S. [1 ]
Basak, E. A. [1 ]
El Bouazzaoui, S. [2 ]
Koolen, S. L. W. [1 ]
van der Leest, C. [3 ]
Sleijfer, S. [1 ]
Debets, R. [1 ]
van Schaik, R. H. N. [2 ]
Aerts, J. G. J. V. [4 ]
Mathijssen, R. [1 ]
机构：
[1] Erasmus MC Canc Inst, Med Oncol, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Clin Chem, Rotterdam, Netherlands
[3] Amphia Hosp, Pulmonol, Breda, Netherlands
[4] Erasmus Univ, Med Ctr, Pulmonol, Rotterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparison between four PD-L1 IHC assays and association with efficacy of Nivolumab in previously treated NSCLC patients regular
    Sato, Yuki
    Fujimoto, Daichi
    Uehara, Keiichiro
    Imaoka, Yuki
    Hayashi, Kentaro
    Ishida, Kaori
    Fukuoka, Junya
    Imai, Yukihiro
    Tomii, Keisuke
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] Association of Candidate Single Nucleotide Polymorphisms Related to Candidate Genes in Patients With Schizophrenia
    Karimian, Seyedeh Sara
    Akbari, Mohammad Taghi
    Sadr, Seyed Saeed
    Javadi, Gholamreza
    BASIC AND CLINICAL NEUROSCIENCE, 2020, 11 (05) : 595 - 608
  • [43] Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib for biliary tract and gastric cancers
    Maeng, C. H.
    Yi, J. H.
    Lee, J.
    Hong, J. Y.
    Choi, M. K.
    Jung, H. A.
    Park, J. O.
    Park, S. H.
    Park, Y. S.
    Lim, H. Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S633 - S633
  • [44] Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma
    Xie, Xiaoxue
    Jin, Hekun
    Hu, Jun
    Zeng, Yong
    Zhou, Jumei
    Ouyang, Shuyu
    Yang, Wenjuan
    Hu, Bingqiang
    Wang, Hui
    ONCOLOGY REPORTS, 2014, 31 (01) : 223 - 231
  • [45] Association between single nucleotide polymorphisms rs12722489 and multiple sclerosis in Iranian patients with multiple sclerosis
    Ahmadi, Habib
    Yassaee, Vahid Reza
    Mirfakhraie, Reza
    Hashemi-Gorji, Feyzollah
    CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (01): : 26 - 31
  • [46] Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients
    Shi, JY
    Shi, ZZ
    Zhang, SJ
    Zhu, YM
    Gu, BW
    Li, G
    Bai, XT
    Gao, XD
    Hu, J
    Jin, W
    Huang, W
    Chen, Z
    Chen, SJ
    PHARMACOGENETICS, 2004, 14 (11): : 759 - 768
  • [47] Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients
    Aslani, Saeed
    Mahmoudi, Mahdi
    Salmaninejad, Arash
    Poursani, Shiva
    Ziaee, Vahid
    Rezaei, Nima
    FETAL AND PEDIATRIC PATHOLOGY, 2017, 36 (03) : 177 - 183
  • [48] Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics
    Huemer, F.
    Rinnerthaler, G.
    Lang, D.
    Hackl, H.
    Lamprecht, B.
    Greil, R.
    ANNALS OF ONCOLOGY, 2019, 30 (04) : 652 - 653
  • [49] Single nucleotide polymorphisms in PD-L1 and outcome in nivolumab-treated advanced non-small-cell lung cancer patients
    Nomizo, T.
    Funazo, T.
    Ozasa, H.
    Tsuji, T.
    Yasuda, Y.
    Yoshida, H.
    Sakamori, Y.
    Nagai, H.
    Hirai, T.
    Kim, Y. H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Single nucleotide polymorphisms (SNPs) of the platinum pharmacogenetic and VEGF pathways: Association with survival of platinum-treated stage IV non-small cell lung cancer (NSCLC) patients
    Cuffe, Sinead
    Qiu, Xiaoping
    Azad, Abul Kalam
    Qiu, Xin
    Boyd, Kevin
    Kuang, Qin
    Marsh, Sharon
    Savas, Sevtap
    Emami, Marjan
    Perera, Nicole
    Palepu, Prakruthi R.
    Chen, Zhuo
    Patel, Devalben
    Cheng, Dangxiao
    Feld, Ronald
    Leighl, Natasha B.
    Shepherd, Frances A.
    Tsao, Ming Sound
    Xu, Wei
    Liu, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345